NOVA COMPLEX HQ- hydroquinone emulsion

País: Estados Unidos

Idioma: inglés

Fuente: NLM (National Library of Medicine)

Ingredientes activos:

HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE)

Disponible desde:

Pharma Cosmetics

Designación común internacional (DCI):

Hydroquinone

Composición:

Hydroquinone 40 mg in 1 g

Vía de administración:

TOPICAL

tipo de receta:

PRESCRIPTION DRUG

indicaciones terapéuticas:

COMPLEX HQ+ is indicated for the gradual lightening of hyperpigmented skin conditions, such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. Sunscreen must be used daily during COMPLEX HQ+ treatment. Skin Bleach

Estado de Autorización:

unapproved drug other

Ficha técnica

NOVA COMPLEX HQ- HYDROQUINONE EMULSION
PHARMA COSMETICS
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this_
_labeling has not been approved by FDA. For further information about
unapproved_
_drugs, click here._
----------
NEOVA COMPLEX HQ+ (HYDROQUINONE 4%)
INDICATIONS & USAGE:
COMPLEX HQ+ is indicated for the gradual lightening of
hyperpigmented skin conditions, such as chloasma, melasma, freckles,
senile
lentigines, and other unwanted areas of melanin hyperpigmentation.
Sunscreen must be used daily during COMPLEX HQ+ treatment.
PURPOSE
Skin Bleach
ACTIVE INGRDIENTS
HYDROQUINONE
KEEP OUT OF REACH OF CHILDREN
Keep out of reach of children
WARNINGS
A. Caution: Hydroquinone is a skin bleaching agent which may produce
unwanted cosmetic effects if not used as directed. The physician
should be
familiar with the contents of this insert before prescribing or
dispensing
this medication.
Test for skin sensitivity before using Hydroquinone Cream by applying
asmall amount
to an unbroken patch of skin and check in 24 hours. Minorredness is
not a
contraindication, but where there is itching or vesicleformation or
excessive
inflammatory response, further treatment is notadvised. Close patient
supervision is
recommended.Contact with the eyes should be avoided. In case of
accidental
contact, pa-
tient should rinse eyes thoroughly with water and contact physician. A
bitter taste
and anesthetic effect may occur if applied to lips. Keep out of reach
of children. If no
bleaching or lightening effect is noted after 2 months oftreatment
use, Hydroquinone
Cream should be discontinued. This product isformulated for use as a
skin bleaching
agent and should not be used for the prevention of sunburn.
Sunscreen use is an essential aspect of Hydroquinone therapy
becauseeven minimal
sunlight exposure sustains melanocytic activity. After clear-ing and
during
maintenance therapy, sun exposure should be avoided on bleached skin
by
application of a sunscreen or sunblock agent, or protective clothing
to prevent
rep